| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/12/2008 | WO2008080045A3 Dr6 antibodies inhibiting the binding of dr6 to app, and uses thereof in treating neurological disorders |
| 09/12/2008 | WO2008079359A3 Human antibodies that bind human il-12 and methods for producing |
| 09/12/2008 | WO2008071447A8 Amino acid sequences that modulate the interaction between cells of the immune system |
| 09/12/2008 | WO2008063996A3 Therapeutic targeting of escort proteins |
| 09/12/2008 | WO2005091856A8 Asthma-related anti-il-13 immunoglobulin derived proteins, compositions, methods and uses |
| 09/12/2008 | CA2680123A1 A fusion polypeptide for detection of conserved combinatorial or composite epitopes in non-conserved proteins |
| 09/12/2008 | CA2679743A1 Methods and compositions involving polymeric immunoglobulin fusion proteins |
| 09/12/2008 | CA2679545A1 Osteopontin for the prediction and treatment of cardiovascular diseases |
| 09/12/2008 | CA2679045A1 Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them |
| 09/12/2008 | CA2678888A1 Human antibodies against hepatitis c virus (hcv) and uses thereof |
| 09/12/2008 | CA2678628A1 Recombinant antibodies for treatment of respiratory syncytial virus infections |
| 09/12/2008 | CA2678465A1 Method of determining nt-probnp |
| 09/11/2008 | US20080222755 Method for modifying plant morphology, biochemistry and physiology |
| 09/11/2008 | US20080222739 Cwp84, FliC and FliD proteins known to have conserved peptide sequences separately injected into female chickens, and the antibody rich egg yolks harvested |
| 09/11/2008 | US20080221309 MN Gene and Protein |
| 09/11/2008 | US20080221308 HDAC9 polypeptides and polynucleotides and uses thereof |
| 09/11/2008 | US20080221307 Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto |
| 09/11/2008 | US20080221306 Humanized antibodies that recognize beta amyloid peptide |
| 09/11/2008 | US20080221027 Administrating a composition to artificially increase sarcospan activity in a muscle tissue of the patient; increasing the dystrophin-related complex |
| 09/11/2008 | US20080221016 Modulating Glucocorticoid Induced TNF Receptor with an agent that binds GITR; binding a fusion protein to a GITR ligand to modulate regulatory T cell function; Multiple Sclerosis, Insulin-Dependent Diabetes Mellitus, Inflammatory Bowel Disease, Ulcerative Colitis, Crohns Disease |
| 09/11/2008 | US20080220538 Novel Cancer Associated Antibodies And Their Use In Cancer Diagnosis |
| 09/11/2008 | US20080220495 DELTA3, FTHMA-070, TANGO85, TANGO77, SPOIL, NEOKINE, TANGO129 and integrin alpha subunit protein and nucleic acid molecules and uses thereof |
| 09/11/2008 | US20080220487 Biosynthesis; bioreduction; biocatalysts; enhanced enantioselectivity for (S)-enantiomer substrate catalytic activity |
| 09/11/2008 | US20080220477 pdCpA is bound to an amino acid such as phenylalanine, tryptophan or tyrosine or derivative allowed to react with 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indecene-3-propionic acid label to form a labeled amino acid-pdCpA conjugate, which is then bound to tRNA(CA-); functional protein synthesis |
| 09/11/2008 | US20080220473 Endo-N-Acetyl-Beta-D-Glucosaminidase Enzymes of Filamentous Fungi |
| 09/11/2008 | US20080220459 Using presence of collagen IX alpha-1chain polypeptide fragments as diagnostic indicator of arthritic, bone, cardiovascular and/or inflammatory disorders |
| 09/11/2008 | US20080220455 p53-DEPENDENT APOPTOSIS-INDUCING PROTEIN AND METHOD OF SCREENING FOR APOPTOSIS REGULATOR |
| 09/11/2008 | US20080220451 T1r2 binding assays |
| 09/11/2008 | US20080220449 Using tau protein phosphorylation profile as diagnostic indicator of neurodegenerative disorders |
| 09/11/2008 | US20080220448 Using trialkylphosphines and sulfhydryl reactive agents as tools in generation of antigenic protein conjugates for use in diagnostic immunoassays |
| 09/11/2008 | US20080220431 Cell fusion method |
| 09/11/2008 | US20080220417 Novel Alanine Transaminase Enzymes and Methods of Use |
| 09/11/2008 | US20080220019 in a cell culture, for use as antibodies or vaccines against hepatitis virus; genetic engineering |
| 09/11/2008 | US20080220008 Mutated Hiv Nef For Modulating Immunity |
| 09/11/2008 | US20080220002 Modified transferin-antibody fusion proteins |
| 09/11/2008 | US20080219999 Immunoadhesin for the prevention of rhinovirus infection |
| 09/11/2008 | US20080219998 Anticoagulant for use in treatment and prevention of thrombosis or thrombin-dependent vaso-occlusive disease; selective reduction of intravascular thromboplastin antecedent activity |
| 09/11/2008 | US20080219997 Her-2 binding antagonists |
| 09/11/2008 | US20080219995 Il-32 monoclonal antibodies and uses thereof |
| 09/11/2008 | US20080219994 Modified bouganin proteins, cytotoxins and methods and uses thereof |
| 09/11/2008 | US20080219993 RalGDS related (RGR) protein specific immunoglobulin for treatment and prevention of cell proliferative disorders |
| 09/11/2008 | US20080219992 Pancreatic protein for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 09/11/2008 | US20080219991 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219990 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219989 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 09/11/2008 | US20080219988 Polypeptide comprising major histocompatibility complex epitopes for targeting and destroying tumor cells |
| 09/11/2008 | US20080219987 Amino acid sequences associated with cell cycle regulating proteins (CDC25b) for use as immunoglobulin targets in treatment of breast and pancreatic tumors; immunotherapy |
| 09/11/2008 | US20080219986 Neisserial protein for use in diagnosis, prevention and treatment of microorganismal infection |
| 09/11/2008 | US20080219985 Prok2 antagonists and methods of use |
| 09/11/2008 | US20080219984 Nucleotide sequences coding myelin-associated glycoprotein receptor for use in identifying modulators for treatment of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease |
| 09/11/2008 | US20080219983 Antihemophilic factor specific peptides for use as therapeutic tools in treatment of blood disorders |
| 09/11/2008 | US20080219982 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219980 Bi-Specific Complexes for Targeting Cells Involved in Allergic-Type Reactions, Compositions and Uses Thereof |
| 09/11/2008 | US20080219976 Methods and compositions for treatment and prevention of staphylococcal infections |
| 09/11/2008 | US20080219974 Transmembrane glycoprotein specific immunoglobulin for use in diagnosis, prevention and treatment of autoimmune diseases |
| 09/11/2008 | US20080219972 Prostatic Acid Phosphatase (Pap) Materials and Methods of Use Thereof in the Prophylactic and Therapeutic Treatment of Prostate Cancer |
| 09/11/2008 | US20080219971 Leukocyte semaphorin specific immunoglobulin for use in prevention and treatment of inflammation, autoimmune, skin, nervous system and/or cell roliferative disorders |
| 09/11/2008 | US20080219970 Identification and molecular characterisation of proteins, expressed in the ixodes ricinus salivary glands |
| 09/11/2008 | US20080219968 Son of sevenless homolog 1 (SOS1) suppressive agent for prevention and treatment of cell proliferative disorders |
| 09/11/2008 | US20080219967 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases |
| 09/11/2008 | US20080219925 Delta opioid receptor protein |
| 09/11/2008 | US20080219924 Imaging, diagnosis and treatment of disease |
| 09/11/2008 | US20080219920 Chimeric, Human and Humanized Anti-CSAP Monoclonal Antibodies |
| 09/11/2008 | US20080219919 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 09/10/2008 | EP1967587A1 APO-3 Ligand |
| 09/10/2008 | EP1967586A1 84P2A9: A prostate and testis specific protein highly expressed in prostate cancer |
| 09/10/2008 | EP1967529A1 Anti-rhesus D recombinant polyclonal antibody and methods of manufacture |
| 09/10/2008 | EP1967528A2 CDR-Grafted type III anti-cea humanized mouse monoclonal antibodies |
| 09/10/2008 | EP1967527A1 A g protein-coupled receptor antagonist and its use for preventing and treating alzheimer s disease |
| 09/10/2008 | EP1967206A2 Anti-IgE vaccines |
| 09/10/2008 | EP1967205A2 Anti-IgE vaccines |
| 09/10/2008 | EP1966613A1 Sensing device and method for determination of the amount of target molecule in an analyte |
| 09/10/2008 | EP1966375A2 Vector for efficient selection and/or maturation of an antibody and uses thereof |
| 09/10/2008 | EP1966246A2 Methods and compositions for needleless delivery of antibodies |
| 09/10/2008 | EP1966245A1 Anti-cd19 antibodies with reduced immunogenicity |
| 09/10/2008 | EP1966244A1 Anti-il-6 antibodies preventing the binding of il-6 complexed with il-6ralpha to gp130 |
| 09/10/2008 | EP1966243A1 Tgf-beta binding compositions |
| 09/10/2008 | EP1966242A1 Ligands that have binding specificity for egfr and/or vegf and methods of use therefor |
| 09/10/2008 | EP1966241A2 Anti-orthopoxvirus recombinant polyclonal antibody |
| 09/10/2008 | EP1631312B1 Compositions and methods for the therapy of inflammatory bowel disease |
| 09/10/2008 | EP1579222B1 Non-competitive immunoassay for small analytes |
| 09/10/2008 | EP1451222B1 Proteins with il-6 inhibiting activity |
| 09/10/2008 | EP1408996B1 A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent |
| 09/10/2008 | EP1381629B1 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN |
| 09/10/2008 | EP1246846B1 Soluble interleukin-20 receptor |
| 09/10/2008 | EP1218537B1 Biallelic markers related to genes involved in drug metabolism |
| 09/10/2008 | EP1200124B1 Erythropoietin-immunoglobulin fusion proteins |
| 09/10/2008 | EP1141017B1 Characterization of the soc/crac calcium channel protein family |
| 09/10/2008 | EP1131356B1 Monoclonal anti alpha-D (ITGAD) antibody for use in the treatment of CNS injuries caused by trauma |
| 09/10/2008 | EP1060247B1 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response |
| 09/10/2008 | EP0983767B1 Preventives or remedies for the treatment of multiple sclerosis containing antagonist anti-IL-6-receptor antibodies |
| 09/10/2008 | CN101263159A Compositions and methods for the diagnosis and treatment of tumor |
| 09/10/2008 | CN101262884A Anti A beta antibody formulation |
| 09/10/2008 | CN101262774A Method of altering the binding specificity of proteins by oxidation-reduction reactions |
| 09/10/2008 | CN101261277A Promyostatin peptides and methods of using same |
| 09/10/2008 | CN101260401A Gene encoding a marker for cancer |
| 09/10/2008 | CN101260156A Immunoglobulin single variant antigen binding domain and specific construct thereof |
| 09/10/2008 | CN101260155A Monoclonal antibody mab-mPrP-N59 of anti-cattle mature prion protein and application thereof |
| 09/10/2008 | CN101260154A Novel mhc II associated peptides |
| 09/10/2008 | CN101260152A Method for down-regulating Osteoprotegerin ligand activity |